跳至主要内容
临床试验/NCT00425256
NCT00425256已完成2 期

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Palatin Technologies, Inc22 个研究点 分布在 1 个国家开始时间: 2006年2月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
试验地点
22

研究概览

简要总结

This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double

入排标准

年龄范围
21 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Post menopausal and in general good health
  • In a stable relationship with a male partner for at least 6 months
  • Willing to attempt sexual activity once a week with your partner

排除标准

  • 未提供

研究者

申办方类型
Industry

研究点 (22)

Loading locations...

相似试验